Abbott Laboratories vs. Royalty Pharma plc Class A Ordinary Shares
ABT
Abbott Laboratories
$109.29 -1.06%
VS RPRXRoyalty Pharma plc Class A Ordinary Shares
$69.45 +0.99%
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| ABT | RPRX | |
|---|---|---|
| Market Cap | $189.28 billion | $30.92 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | RPRX | |
|---|---|---|
| Dividend Yield | 2.31% | 1.35% |
ABT leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | RPRX | |
|---|---|---|
| Short Interest | 0.57% | 0.34% |
RPRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, RPRX overview, RPRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.